The Ambulatory Medical Assistance (AMA) programme during active-phase treatment in patients with haematological malignancies: A cost-effectiveness analysis.

ABSTRACT:

Context

The need for patient navigator is growing, and there is a lack of cost evaluation, especially during survivorship.

Objective

The objective of this study is to evaluate the cost-effectiveness of an Ambulatory Medical Assistance (AMA) programme in patients with haematological malignancies (HM).

Design

A cost-effectiveness analysis of the AMA programme was performed compared to a simulated control arm.

Setting

An interventional, single-arm and prospective study was conducted in a French reference haematology-oncology centre between 2016 and 2020.

Participants

Adult patients were enrolled with histologically documented malignant haematology, during their active therapy phase, and treated either by intravenous chemotherapy or oral therapy.

Methods<

SUBMITTER: Michallet AS 

PROVIDER: S-EPMC9786720 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature